PORTLAND, Ore. (TheStreet) -- It's good to see Godzilla back in giant, radioactive fire-breathing form, but the giant movie monster will never be bigger in the U.S. than it was 60 years ago.
With all respect to lead actor Bryan Cranston, director Gareth Edwards and the folks at Legendary Pictures, this year's Godzilla incarnation could make $1 billlion at the box office and never have the impact of 1956's Godzilla: King Of The Monsters. I said it five years ago in The Huffington Post and I'll say it here: It is the single most important foreign film in U.S. history.
Even though it wasn't even the best version of that film available, it made foreign film palatable to what was a fairly xenophobic American moviegoing audience. It made everything from The Seven Samurai to last year's Instructions Not Included fair game for U.S. cinema screens. But it didn't do so easily. The U.S. movie market in 1956 wasn't exactly a cardboard city that Godzilla could wade into and trample. There weren't a whole lot of foreign films screened here and those that were didn't come with subtitles. Toho had tapped directly into Japan's deepest post-World War II fears when Gojira was released in 1954. Less than a decade after having atomic bombs dropped on Hiroshima and Nagasaki by the United States at the end of World War II, Japan was dealing with the literal fallout of U.S. atomic testing in the Pacific. The Castle Bravo test of a 15-megaton hydrogen bomb on the Bikini Atoll in 1954 scorched the crew of the nearby Japanese fishing boat Lucky Dragon 5 with radiation and tainted the food supply with radioactive fish. Gojira didn't flinch from public reaction to that incident and showed children being treated for radiation burns and families incinerated: A fantastic recap video at Slate goes into greater detail, but basically the dark nature of Gojira wasn't going to fly with a U.S. audience that liked its movie monsters more like 1933's King Kong -- which was rereleased in 1952 and 1956 -- and 1953's Beast From 1,000 Fathoms.
10 Best Up And Coming Stocks To Watch Right Now: Hyperion Therapeutics Inc (HPTX)
Hyperion Therapeutics, Inc. (Hyperion), incorporated in November 2006, is a development-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology. The Company develops Ravicti (glycerol phenylbutyrate) to treat the prevalent urea cycle disorders (UCD) and hepatic encephalopathy (HE). The Company has completed two Phase II trials and one pivotal Phase III trial of Ravicti. The Company�� HE clinical program consists of two trials, which have enrolled patients with cirrhosis. On December 23, 2011, the Company submitted a new drug application (NDA) for Ravicti for the chronic management of UCD in patients aged six years and above based on data from its pivotal Phase III trial in adult patients and the results of two Phase II trials, one in adults and one in pediatric patients aged 6 through 17 years. In June 2013, Hyperion Therapeutics Inc announced that the completion of its acquisition of BUPHENYL (sodium phenylbutyrate) Tablets and Powder from Ucyclyd Pharma Inc., a subsidiary of Valeant Pharmaceuticals International, Inc.
In June 2011, the Company completed a 24-month carcinogenicity study of Ravicti in rats. On March 22, 2012, pursuant to an asset purchase agreement (purchase agreement) with Ucyclyd Pharma, Inc., a wholly owned subsidiary of Medicis Pharmaceutical Corporation, the Company purchased all of the worldwide rights to Ravicti. The Company also has an option to acquire all of Ucyclyd�� worldwide rights in BUPHENYL and AMMONUL (sodium phenylacetate and sodium benzoate) injection.
The Company conducted a pivotal Phase III trial of Ravicti in adult patients 18 years of age or older with UCD. The Company completed a second Phase II trial at five centers in North America in UCD patients aged 6 through 17 years. This trial includes two phases: a two-week, open-label, safety, tolerability, pharmacokinetic characteristics and ammonia control of Ravicti. The Co! mpany enrolled 77 adult and pediatric UCD patients in its two 12-month open-label safety studies, 69 of whom completed the studies. The Company conducted nonclinical genotoxicity and carcinogenicity studies to assess the tumorigenic potential of Ravicti in animals and to assess the relevant risk in humans. The Company is conducting a Phase II multi-center study of patients with cirrhosis and episodic HE.
Advisors' Opinion:- [By Jesse Solomon]
NPS Pharmaceuticals (NPSP), for example, created a drug for treating short bowel syndrome. And Hyperion Therapeutics (HPTX) is developing a drug for hepatic encephalopathy, a decline of brain function that according to the National Institute of Health occurs when the liver is no longer able to remove toxins from the blood. Those stocks are up 20% and 40%, respectively, this year.
- [By Sean Williams]
What: Shares of Hyperion Therapeutics (NASDAQ: HPTX ) , a biopharmaceutical company focused on treatments for orphan diseases and hepatology, rose as much as 10% after receiving orphan drug exclusivity status for Ravicti from the Food and Drug Administration, and exercising an option to acquire two additional urea cycle drugs from Valeant Pharmaceuticals (NYSE: VRX ) .
Top 5 Industrial Disributor Stocks To Invest In 2014: BV Financial Inc (BVFL)
BV Financial, Inc. (BV Financial), is a federally-chartered savings and loan holding company and the holding company for Bay-Vanguard Federal, a federally-chartered savings bank. BV Financial�� business activity is the ownership of the Bay-Vanguard Federal. The Company operates as a community-oriented financial institution offering traditional financial services to consumers and businesses in its market area. It attracts deposits from the general public and uses those funds to originate one- to four-family real estate, mobile home, construction, multi-family, commercial real estate, and consumer loans, which it hold for investment. The Company operates two branch offices in Baltimore City and two branch offices in Anne Arundel County. In June 2013, BV Financial Inc's Bay-Vanguard Federal Savings Bank acquired Vigilant Federal Savings Bank.
Lending Activities
The Company�� loan portfolio consists primarily of one- to four-family residential real estate loans. Its loan portfolio includes mobile home loans, construction loans, multi-family, commercial real estate loans, and consumer loans. As of June 30, 2009, Bay-Vanguard Federal had no loans that were held for sale. Its primary lending activity is the origination of mortgage loans to enable borrowers to purchase or refinance existing homes in its market area. It only offer fixed and adjustable rate mortgage loans and primarily with terms of 15, 20 or 30 years. The Company also offers adjustable-rate mortgage loans with interest rates and payments that adjust annually or every three years.
The Company originates mobile home loans directly and purchase mobile home loans from Forward National and Mainland Financial, which specialize in mobile home lending. As of June 30, 2009, 13.6% of its mobile home portfolio was originated by directly and 70.4% and 16% was purchased from Forward National and Mainland Financial, respectively. As of June 30, 2009, it had 340 mobile home loans, the average size of which was appr! oximately $34,000. Its mobile home loans, which are made primarily to borrowers in Maryland and Pennsylvania, have terms of up to 25 years and fixed interest rates. It originates loans to individuals and, to a lesser extent, builders to finance the construction of residential dwellings. It also make construction loans for commercial development projects, including condominiums, apartment buildings, mixed-use properties with residential units, as well as retail space and owner-occupied properties used for business.
The Company offers fixed-rate and adjustable-rate mortgage loans secured by multi-family and commercial real estate. Its multi-family and commercial real estate loans are secured by condominiums, apartment buildings and mixed-use properties with residential units, as well as retail space. It originates multi-family and commercial real estate loans for terms up to 25 years. The Company�� other consumer loans are primarily loans secured by passbook or certificate accounts, automobile and boat loans and secured personal loans.
Investment Activities
The Company has legal authority to invest in various types of liquid assets, including the United States Treasury obligations, securities of various federal agencies and municipal governments, deposits at the Federal Home Loan Bank of Atlanta and certificates of deposit of federally insured institutions. As of June 30, 2009, its investment portfolio totaled $13.8 million and consisted primarily of the United States Treasury obligations and federal agency securities, mortgage-backed securities issued primarily by Fannie Mae, Freddie Mac and Ginnie Mae, and a mutual fund that invests in adjustable-rate mortgages.
Deposit Activities and Other Sources of Funds
Deposits and loan repayments are the major sources of its funds for lending and other investment purposes. The Company�� deposits are attracted from within its market area through the offering of selection of deposit instruments,! includin! g checking accounts, negotiable order of withdrawal (NOW) and money market accounts, passbook and savings accounts, and certificates of deposit. As of June 30, 2009, its core deposits, which consist of savings, NOW and money market accounts, consists 49% of its deposits.
Advisors' Opinion:- [By CRWE]
Today, BVFL remains (0.00%) +0.000 at $6.52 thus far (ref. google finance Delayed: 3:05PM EDT September 4, 2013).
BV Financial, Inc. previously reported net income of $488,000, or $0.20 per diluted share, for the year ended June 30, 2013 compared to $1,073,000, or $0.46 per diluted share, for the year ended June 30, 2012. Results for 2013 were impacted by the acquisition of Vigilant Federal Savings Bank on May 31, 2013. As a result of the acquisition, BV Financial acquired $47.5 million in assets, $44.4 million in liabilities and created $119,000 in goodwill.
Top 5 Industrial Disributor Stocks To Invest In 2014: Advanced Semiconductor Engineering Inc (ASX)
Advanced Semiconductor Engineering, Inc. is principally engaged in the manufacture, assembly, processing, testing and distribution of integrated circuits (ICs). The Company provides semiconductor packaging and testing services, including plastic leaded chip carriers (PLCCs), quad flat packages (QFPs) and flip chip packaging technology, among others, which are applied in the manufacture of household electrical appliances, communication devices, automobile components, personal computers, set top boxes, servers, memory integrated circuits (ICs), mobile phones, digital cameras, game consoles, projectors, high definition (HD) televisions, wireless communication network products and power management ICs, among others. The Company operates its businesses primarily in Taiwan, Europe and the Americas. In August 2010, the Company acquired a 100% interest in EEMS Test Singapore.
The Company is focused on packaging and testing logic semiconductors. The Company offers its customers turnkey services, which consist of packaging, testing and direct shipment of semiconductors to end users designated by its customers. The Company�� global base of over 200 customers includes semiconductor companies across a range of end use applications, including Altera Corporation, ATI Technologies, Inc., Broadcom Corporation, Cambridge Silicon Radio Limited and Microsoft Corporation. During the year ended December 31, 2008, the Company�� packaging revenues accounted for 77.7% of its net revenues and its testing revenues accounted for 20.1% of its net revenues.
Packaging Services
The Company offers a range of package types to meet the requirements of its customers, with a focus on packaging solutions. Within its portfolio of package types, the Company focuses on the packaging of semiconductors. These include advanced leadframe-based package types, such as quad flat package, thin quad flat package, bump chip carrier and quad flat no-lead package, and package types based on substrates, such a! s flip-chip ball grid array (BGA) and other BGA types, as well as other packages, such as wafer-bumping products. Leadframe-based packages are packaged by connecting the die, using wire bonders, to the leadframe with gold wire. The Company�� leadframe-based packages include quad flat package (QFP)/ thin quad flat package (TQFP), quad flat no-lead package (QFN)/microchip carrier (MCC), advanced quad flat no-lead package (AQFN), bump chip carrier (BCC), small outline plastic package (SOP)/thin small outline plastic package (TSOP), small outline plastic j-bend package (SOJ), plastic leaded chip carrier (PLCC) and plastic dual in-line package (PDIP). Substrate-based packages employ the BGA design, which utilizes a substrate rather than a leadframe. It also assembles system-in-a-package products, which involve the integration of more than one chip into the same package. The Company�� substrate-based packages include Plastic BGA, Cavity Down BGA, Stacked-Die BGA, Flip-Chip BGA and land grid array (LGA).
The Company�� wafer-level packaging products include wafer level chip scale package (aCSP) and advanced wafer level package (aWLP). The Company offers module assembly services, which combine one or more packaged semiconductors with other components in an integrated module to enable functionality, typically using surface mount technology (SMT) machines and other machinery and equipment for system-level assembly. End use applications for modules include cellular phones, personal digital assistant (PDAs), wireless local area network (LAN) applications, bluetooth applications, camera modules, automotive applications and toys.
The Company provides module assembly services primarily at its facilities in Korea for radio frequency and power amplifier modules used in wireless communications and automotive applications. Interconnect materials connect the input/output on the semiconductor dies to the printed circuit board. Interconnect materials include substrate, which is a multi-layer m! iniature ! printed circuit board. The Company produces substrates for use in its packaging operations.
Testing Services
The Company provides a range of semiconductor testing services, including front-end engineering testing, wafer probing, final testing of logic/mixed-signal/radio frequency (RF) and memory semiconductors and other test-related services. The Company provides front-end engineering testing services, including customized software development, electrical design validation, and reliability and failure analysis. The Company provides final testing services for a variety of memory products, such as static random access memory (SRAM), dynamic random access memory (DRAM), single-bit erasable programmable read-only memory semiconductors and flash memory semiconductors.
The Company provides a range of additional test-related services, including burn-in testing, module sip testing, dry pack, tape and reel, and electric interface board and mechanical test tool design. The Company offers drop shipment services for shipment of semiconductors directly to end users designated by its customers.
Advisors' Opinion:- [By David Dittman]
Crown Resorts is a buy all the way up to USD16.50 on the Australian Securities Exchange (ASX) using the symbol CWN and on the US over-the-counter (OTC) market using the symbol CWLDF.
- [By Jeff Reeves]
Next Page
Best Stocks to Buy for Around $5: Advanced Semiconductor Engineering (ASX)Advanced Semiconductor Engineering�(ASX) builds and distributes integrated circuits and other electronics. While that�� not as sexy as other chipmakers that play to mobile, it�� still a good business, considering the general demand for microchips in everything from cars to computers to TVs.
Top 5 Industrial Disributor Stocks To Invest In 2014: Tim Participacoes SA (TIMP3)
TIM Participacoes SA (TIM) is a Brazil-based holding company engaged in the telecommunications segment. Through its wholly-owned subsidiaries, TIM Celular SA (TIM Celular) and Intelig Telecomunicacoes Ltda (Intelig), it provides telecommunication services throughout Brazil. TIM Celular and Intelig are active as Public Switched Telephony Network (PSTN) providers in the local and national and international long-distance modalities in all Brazilian states. Additionally, the Company provides multimedia communication services and personal mobile services, mobile data services and a third generation (3G) network, as well as international roaming agreements, multimedia messaging services, blackberry services and sale of related equipment. Advisors' Opinion:- [By Inyoung Hwang]
Telecom Italia climbed 5.2 percent to 64.2 euro cents, its highest price since May. The telecommunications operator would gain enough funds to improve its domestic business if it sells at least 4 billion euros ($5.4 billion) of shares or its stake in Tim Participacoes SA (TIMP3) in Brazil, according to Goldman Sachs.
- [By Zahra Hankir]
Brazil�� Ibovespa extended its weekly decline to 3.3 percent. Mobile carrier Tim Participacoes SA (TIMP3) sank after parent Telecom Italia SpA (TIT)�� chief executive officer said its Brazilian assets are strategic, damping speculation the local unit will be sold.
- [By Jonathan Morgan]
Telecom Italia SpA (TIT) jumped 6.2 percent to 65.6 euro cents. The phone company that was stripped of its investment-grade rating is seeking at least 9 billion euros for its controlling stake in Brazilian wireless carrier Tim Participacoes SA (TIMP3), according to a person with direct knowledge of the matter.
No comments:
Post a Comment